Indoco Remedies (NSE:INDOCO) Other Current Payables: ₹0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:INDOCO Indoco Remedies Ltd NSE:INDOCO
67 GF Score
Price ₹248.14
GF Value ₹364.57
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Indoco Remedies Other Current Payables?

Indoco Remedies NSE:INDOCO +1.94% 67 Other Current Payables is ₹0 Mil as of Jun. 2026. GuruFocus rates NSE:INDOCO with a GF Score™ of 67/100 and a GF Value™ of ₹364.57 (Possible Value Trap). The stock has 5 warning signs investors should review.

Indoco Remedies's Other Current Payables for the quarter that ended in Jun. 2026 was ₹0 Mil.

Indoco Remedies's annual Other Current Payables increased from Mar. 2024 (₹481 Mil) to Mar. 2025 (₹611 Mil) but then declined from Mar. 2025 (₹611 Mil) to Mar. 2026 (₹0 Mil).

Indoco Remedies Other Current Payables Related Terms

Indoco Remedies Other Current Payables Historical Data

* Premium members only.

The historical data trend for Indoco Remedies's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Indoco Remedies Other Current Payables Chart

Indoco Remedies Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Other Current Payables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 41.18 363.39 480.84 610.60 0.00

Indoco Remedies Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Other Current Payables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
NSE:INDOCO
67GF Score
Indoco Remedies Ltd NSE:INDOCO
Other Current Payables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Indoco Remedies Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.

Frequently Asked Questions Learn more about Other Current Payables →
What does a Other Current Payables of ₹0 Mil mean?
Indoco Remedies (NSE:INDOCO) has a Other Current Payables of ₹0 Mil as of Jun. 2026. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Indoco Remedies and its competitors.
Is Indoco Remedies' Other Current Payables too high?
Indoco Remedies' current Other Current Payables is ₹0 Mil. Overall, Indoco Remedies has a GF Score™ of 67/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Indoco Remedies' Other Current Payables compare to ZTS?
Indoco Remedies' Other Current Payables of ₹0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Payables for a Drug Manufacturers company?
A good Other Current Payables depends on the Drug Manufacturers industry context. However, Other Current Payables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Payables mean?
A high Other Current Payables can signal that a stock is expensive relative to its fundamentals. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Indoco Remedies and its competitors. Indoco Remedies's current Other Current Payables is ₹0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Indoco Remedies stock overvalued right now?
Based on GuruFocus' analysis, Indoco Remedies (NSE:INDOCO) is currently considered Possible Value Trap. The stock's GF Value™ is ₹364.57, compared to a current price of ₹248.14 — trading 31.9% below its estimated fair value. The current Other Current Payables is ₹0 Mil. Indoco Remedies' overall GF Score™ is 67/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Payables calculated?
Other Current Payables is calculated from a company's financial statements. For Indoco Remedies (NSE:INDOCO), the current Other Current Payables is ₹0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Indoco Remedies (NSE:INDOCO) Overvalued in 2026?

Based on GuruFocus' analysis, Indoco Remedies stock appears to be undervalued. The current stock price of ₹248.14 is trading 31.9% below its estimated GF Value™ of ₹364.57. GuruFocus considers Indoco Remedies to be Possible Value Trap.

Key valuation signals for NSE:INDOCO:

  • Other Current Payables: ₹0 Mil
  • GF Value™: ₹364.57 vs. price of ₹248.14 (31.9% below fair value)
  • GF Score™: 67/100 with 5 warning signs

No single metric tells the full story. See the NSE:INDOCO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Indoco Remedies Business Description

Other Exchanges 532612:India
Address 166 CST Road, Indoco House, Kalina, Santacruz (East), Mumbai, MH, IND, 400 098
Indoco Remedies Ltd is an India-based pharmaceutical company. The company is engaged in the manufacturing and marketing of formulations (finished dosage forms) and active pharmaceutical ingredients (APIs). The company manufactures products for different therapeutic sectors including Gastroenterology, Dentistry & Stomatology, Respiratory, Diabetology, Women's Health, Nutritional products, Cardiology, Metabolic Disorders, and Primary Care medicines. The only operating segment of the company is Pharmaceutical Products. Geographically, it generates the majority of the revenue from India.
67GF Score

Get the complete analysis for NSE:INDOCO

Other Current Payables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹248.14
Price
₹364.57
GF Value